Skip to content
AwardedBelgiumGoods

Bévacizumab

Published
Published 11 February 2025
Deadline
Closed 13 March 2025

Overview

Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif "Bévacizumab" pour injection en flacons "ready to use" de 100 mg et 400 mg

Key details

Country
Belgium
Status
Awarded
Category
Goods
Procedure
Open
Published
11 February 2025
Deadline
Closed
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€852,189
Award date
4 April 2025
Contract period
— → 14 March 2029
Winner
  • Pfizer

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    7 April 2025

  2. Contract Notice

    11 February 2025

Contracting authority

  • Cliniques universitaires Saint Luc

    Procuring entity

    Woluwe-Saint-Lambert, Belgium

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Bévacizumab — won by Pfizer — Skim